Detection of autoantibodies to neural cells of the cerebellum in the plasma of subjects with autism spectrum disorders

• Published in: Brain, behavior, and immunity Vol. 23; no. 1; pp. 64 - 74
• Main Authors: Wills, Sharifia, Cabanlit, Maricel, Bennett, Jeff, Ashwood, Paul, Amaral, David G., Van de Water, Judy
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Inc 01.01.2009
• Subjects: Adolescent; Allergy and Immunology; Animals; Autism spectrum disorders (ASD); Autistic Disorder - blood; Autistic Disorder - immunology; Autoantibodies - blood; Autoantibodies - immunology; Autoantibody; Blotting, Western; Brain; Cerebellum; Cerebellum - metabolism; Cerebellum - pathology; Child; Child, Preschool; Female; Golgi cell; Humans; Immune; Immunohistochemistry; Macaca fascicularis; Male; Nerve Tissue Proteins - immunology; Nerve Tissue Proteins - metabolism; Neurons - metabolism; Neurons - pathology; Psychiatry; Siblings; Cerebellum; Immunohistochemistry; Brain; Golgi cell; Immune; Autoantibody; Autism spectrum disorders (ASD)
• ISSN: 0889-1591; 1090-2139; 1090-2139
• DOI: 10.1016/j.bbi.2008.07.007

Autism spectrum disorders (ASD) are a group of heterogeneous, behaviorally defined disorders characterized by disturbances in social interaction and communication, often with repetitive and stereotyped behavior. Previous studies have described the presence of antibodies to various neural proteins in autistic individuals as well as post-mortem evidence of neuropathology in the cerebellum. We examined plasma from children with ASD, as well as age-matched typically developing controls, for antibodies directed against human cerebellar protein extracts using Western blot analysis. In addition, the presence of cerebellar specific antibodies was assessed by immunohistochemical staining of sections from Macaca fascicularis monkey cerebellum. Western blot analysis revealed that 13/63 (21%) of subjects with ASD possessed antibodies that demonstrated specific reactivity to a cerebellar protein with an apparent molecular weight of approximately 52 kDa compared with only 1/63 (2%) of the typically developing controls ( p = 0.0010). Intense immunoreactivity, to what was determined morphologically to be the Golgi cell of the cerebellum, was noted for 7/34 (21%) of subjects with ASD, compared with 0/23 of the typically developing controls. Furthermore, there was a strong association between the presence of antibodies reactive to the 52 kDa protein by Western blot with positive immunohistochemical staining of cerebellar Golgi cells in the ASD group ( r = 0.76; p = 0.001) but not controls. These studies suggest that when compared with age-matched typically developing controls, children with ASD exhibit a differential antibody response to specific cells located in the cerebellum and this response may be associated with a protein of approximately 52 kDa.